What is the difference between obeticholic acid and ursodecholic acid? What are the differences in the mechanisms, efficacy, and side effects of these two drugs?

Obeticholic acid and Ursodeoxycholic acid are two bile acid drugs used to treat liver diseases. Although they are closely related to bile acid metabolism, they have significant differences in mechanisms, efficacy and side effects. The differences between these two drugs will be analyzed in detail below.

1. Mechanism differences

Obeeticholic acid is a synthetic bile acid derivative that works primarily by activating the farnesoidX receptor (FXR). FXR is a nuclear receptor that plays an important role in regulating bile acid synthesis, bile acid metabolism, and cholesterol and lipid metabolism. Obeticholic acid reduces bile acid synthesis and reduces inflammatory reactions in the liver by activating FXR, which can effectively improve liver diseases related to abnormal bile acid metabolism, such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).

Usodecholic acid (UDCA) is a natural bile acid commonly used to treat liver diseases caused by cholestasis, such as primary biliary cholangitis (PBC), cholelithiasis and some liver damage. Its mechanism of action is different from that of obeticholic acid. Ursodecholic acid mainly protects the liver by reducing the toxicity of bile acids, improving the stability of liver cell membranes, promoting bile flow, and reducing cholestasis. Ursodecholic acid also improves liver function by increasing bile excretion from the liver.

2. Effectiveness comparison

Obeticholic acid is primarily used to treat primary biliary cholangitis (PBC), especially in patients who have failed to respond to ursodecholic acid therapy. Studies have shown that obeticholic acid can effectively reduce liver inflammation and improve liver function indicators, such as ALT and AST levels. Especially in patients who have failed ursodecholic acid treatment, obeticholic acid has shown stronger efficacy. The anti-inflammatory effect of obeticholic acid on the liver makes it one of the important treatment options for PBC patients.

In contrast, the main indication for ursodecholic acid is mild to moderate primary biliary cholangitis (PBC), especially in early-stage cholestatic liver disease. Ursodecholic acid can reduce cholestasis and improve liver function, but its efficacy is limited in patients with advanced or severe PBC. The therapeutic effect of ursodecholic acid is relatively mild and is suitable for patients with mild disease who tolerate the drug well.

3. Side Effect Comparison

Obeticholic acid and ursodecholic acid have different side effects. Obeticholic acid has relatively many side effects, especially problems such as abnormal liver function, gastrointestinal discomfort (such as diarrhea, nausea, etc.), rash, etc. that may occur during use. In addition, obeticholic acid may cause an increase in blood lipid levels, so regular monitoring of cholesterol and triglyceride levels is required. Obeticholic acid has significant side effects, so the patient's liver function and overall health need to be paid close attention to during treatment.

Ursodecholic acid has relatively few side effects. Common adverse reactions include mild gastrointestinal discomfort, such as diarrhea, abdominal pain, etc., which can usually be relieved after dose adjustment. Ursodecholic acid has mild clinical side effects, making its use safer, especially for long-term treatment. However, ursodecholic acid may also cause abnormal liver function in some cases, especially if the patient has other liver problems, so liver function needs to be monitored regularly.

4. Differences in indications

Obeticholic acid is mainly used to treat patients with primary biliary cholangitis (PBC), especially those who are ineffective or resistant to ursodecholic acid treatment. In addition, obeticholic acid has also shown efficacy in other diseases related to abnormal bile acid metabolism, such as non-alcoholic fatty liver disease (NAFLD) and primary sclerosing cholangitis (PSC).

Ursodecholic acid is suitable for a variety of cholestatic diseases, such as primary biliary cholangitis, gallstones, biliary tract diseases and certain liver diseases. Ursodecholic acid's broad indications make it a common choice for the treatment of cholestatic diseases, especially in patients with less severe disease.

Obeticholic acid and ursodecholic acid have significant differences in their mechanisms, efficacy, side effects, and indications. Obeticholic acid mainly activates FXR and is suitable for PBC patients who are ineffective against ursodecholic acid. It has a strong anti-inflammatory effect; ursodecholic acid reduces the toxicity of bile acids by improving bile flow and is mainly used to treat early cholestatic liver disease. There are obvious differences in side effects between the two. Obeticholic acid has more obvious side effects, while ursodecholic acid has relatively mild side effects. When choosing a treatment plan, patients should make decisions based on the doctor's advice and their own condition.

Reference materials:https://en.wikipedia.org/wiki/Obeticholic_acid